Clinical trials
Coronary Artery Disease trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Unknown status | 11 |
| Active, not recruiting | 9 |
| Recruiting | 4 |
| Terminated | 3 |
| Temporarily not available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charles University, Czech Republic | 5 |
| Abbott Medical Devices | 4 |
| University Hospital, Motol | 3 |
| AstraZeneca | 2 |
| CSL Behring | 2 |
| Gilead Sciences | 2 |
| OrbusNeich | 2 |
| Terumo Europe N.V. | 2 |
| University Hospital Ostrava | 2 |
| Weill Medical College of Cornell University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 59 |
| Myocardial Infarction | 8 |
| Heart Diseases | 7 |
| Cardiovascular Diseases | 6 |
| Myocardial Ischemia | 6 |
| Acute Coronary Syndrome | 5 |
| Angina Pectoris | 5 |
| Atherosclerosis | 4 |
| Coronary Disease | 4 |
| Peripheral Arterial Disease | 4 |
Trials
Showing 51 to 59 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.